Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05603910
Title Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Aaron Wolfson
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST